Potential of CME@ZIF‑8\nMOF Nanoformulation:\nSmart Delivery of Silymarin for Enhanced Performance and Mechanism\nin Albino Rats

Silymarin,\nan antioxidant, is locally used for kidney\nand heart\nailments. However, its limited water solubility and less oral bioavailability\nlimit its therapeutic efficiency. The present study investigated the\nenhancement of solubility and bioavailability of silymarin by loading\nit in Cordia myxa plant extract-coated\nzeolitic imidazole framework (CME@ZIF-8) against carbon tetrachloride\n(CCl<sub>4</sub>)-induced nephrotoxicity and cardiac toxicity in albino\nrats. The synthesized PEG-coated silymarin drug-loaded CME@ZIF-8 MOFs\n(PEG-Sily@CME@ZIF-8) were characterized by scanning electron microscopy,\ntransmission electron microscopy, high-resolution transmission electron\nmicroscopy, energy dispersive X-ray spectroscopy, UV–visible\nspectroscopy, X-ray diffraction, Fourier transform infrared spectroscopy,\nthermogravimetric analysis, and zeta potential. The average crystal\nsize of CME@ZIF-8 and PEG-Sily@CME@ZIF-8 was 12.69 and 16.81 nm, respectively.\nThe silymarin drug loading percentage in PEG-Sily@CME@ZIF-8 was 33.05%\n(w/w). In the animal model with CCl<sub>4</sub> treatment, different\nparameters like serum profile, enzymatic level, genotoxicity, and\nhistopathology were assessed. Treatment with PEG-Sily@CME@ZIF-8 with\ndifferent doses of 500, 1000, and 1500 μg/kg body weight efficiently\nameliorated the alterations in the antioxidant defenses, biochemical\nparameters, and histopathological alterations and DNA damage in comparison\nto silymarin drug in a CCl<sub>4</sub>-induced toxicity rat model\nvia alleviating the cellular abnormalities and attenuation of normal\nantioxidant enzymes levels. Moreover, the molecular mechanism of drug–silymarin\ninteraction with the target protein was investigated. It involves\nthe binding pockets of silymarin molecules with VEGFR, TNF-α,\nNLRP3, AT1R, NOX1, RIPK1, Caspase-3, CHOP, and MMP-9 proteins, elucidating\nthe silymarin–protein interactions by the formation of hydrogen\nbonds and hydrophobic interactions. This study suggests that the nanodrug\nPEG-Sily@CME@ZIF-8 MOFs protect the kidneys and heart possibly by\nmitigating oxidative stress more efficiently than the conventional\ndrug silymarin.

Publication Details

Journal
Figshare
Published
2024-09-30
DOI
https://doi.org/10.1021/acsabm.4c01019.s001
Primary Topic
Silymarin and Mushroom Poisoning
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Potential of CME@ZIF‑8\nMOF Nanoformulation:\nSmart Delivery of Silymarin for Enhanced Performance and Mechanism\nin Albino Rats

Figshare
Silymarin and Mushroom Poisoning
article

Potential of CME@ZIF‑8\nMOF Nanoformulation:\nSmart Delivery of Silymarin for Enhanced Performance and Mechanism\nin Albino Rats

article en

Abstract

Silymarin,\nan antioxidant, is locally used for kidney\nand heart\nailments. However, its limited water solubility and less oral bioavailability\nlimit its therapeutic efficiency. The present study investigated the\nenhancement of solubility and bioavailability of silymarin by loading\nit in Cordia myxa plant extract-coated\nzeolitic imidazole framework (CME@ZIF-8) against carbon tetrachloride\n(CCl<sub>4</sub>)-induced nephrotoxicity and cardiac toxicity in albino\nrats. The synthesized PEG-coated silymarin drug-loaded CME@ZIF-8 MOFs\n(PEG-Sily@CME@ZIF-8) were characterized by scanning electron microscopy,\ntransmission electron microscopy, high-resolution transmission electron\nmicroscopy, energy dispersive X-ray spectroscopy, UV–visible\nspectroscopy, X-ray diffraction, Fourier transform infrared spectroscopy,\nthermogravimetric analysis, and zeta potential. The average crystal\nsize of CME@ZIF-8 and PEG-Sily@CME@ZIF-8 was 12.69 and 16.81 nm, respectively.\nThe silymarin drug loading percentage in PEG-Sily@CME@ZIF-8 was 33.05%\n(w/w). In the animal model with CCl<sub>4</sub> treatment, different\nparameters like serum profile, enzymatic level, genotoxicity, and\nhistopathology were assessed. Treatment with PEG-Sily@CME@ZIF-8 with\ndifferent doses of 500, 1000, and 1500 μg/kg body weight efficiently\nameliorated the alterations in the antioxidant defenses, biochemical\nparameters, and histopathological alterations and DNA damage in comparison\nto silymarin drug in a CCl<sub>4</sub>-induced toxicity rat model\nvia alleviating the cellular abnormalities and attenuation of normal\nantioxidant enzymes levels. Moreover, the molecular mechanism of drug–silymarin\ninteraction with the target protein was investigated. It involves\nthe binding pockets of silymarin molecules with VEGFR, TNF-α,\nNLRP3, AT1R, NOX1, RIPK1, Caspase-3, CHOP, and MMP-9 proteins, elucidating\nthe silymarin–protein interactions by the formation of hydrogen\nbonds and hydrophobic interactions. This study suggests that the nanodrug\nPEG-Sily@CME@ZIF-8 MOFs protect the kidneys and heart possibly by\nmitigating oxidative stress more efficiently than the conventional\ndrug silymarin.

Figshare
Clean water and sanitation
Openalex Percentile: Top 51%
Silymarin and Mushroom Poisoning
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.